Contract facts
FederalNo full NAICS 621511 intel page yet. Browse NAICS intelligence
ONCOLOGY COST PER REPORTABLE TEST is a federal award for 250-Network Contract Office 10 (36C250) held by Hematologics, Inc. Estimated value $689K ($221K obligated). Current period of performance ends Jun 30, 2023. Last award drew 1 bidder. Place of performance: CINCINNATI OH.
Recompete timing
PublicCurrent PoP ended Jun 30, 2023 (1148 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25020F0894?
36C25020F0894 (Oncology COST PER reportable TEST) is a 250-Network Contract Office 10 (36C250) award with a potential value of $689K, currently held by Hematologics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C250-20-F-0894?
36C250-20-F-0894 is the dashed form of PIID 36C25020F0894 (Oncology COST PER reportable TEST), held by Hematologics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25020F0894?
250-Network Contract Office 10 (36C250) awarded 36C25020F0894 to Hematologics, Inc (potential $689K).
Who is the incumbent on 36C25020F0894?
Hematologics, Inc is the incumbent. The current period of performance ends Jun 30, 2023.
When does Hematologics, Inc’s 36C25020F0894 come up for recompete?
SCOUT tracks a period-of-performance end of Jun 30, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.